v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive income (loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024   0 4,033        
Beginning treasury balance (in shares) at Dec. 31, 2024             (1,283)
Beginning balance at Dec. 31, 2024 $ 40,428 $ 0 $ 4 $ 494,209 $ (430,017) $ (2,717) $ (21,051)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation (in shares)     2        
Stock-based compensation 386     386      
Purchase of net settled restricted stock (in shares)             (1)
Purchase of net settled restricted stock (8)           $ (8)
Accumulated other comprehensive income (loss) 424         424  
Net loss (1,756)       (1,756)    
Ending balance (in shares) at Mar. 31, 2025   0 4,035        
Ending treasury balance (in shares) at Mar. 31, 2025             (1,284)
Ending balance at Mar. 31, 2025 39,474 $ 0 $ 4 494,595 (431,773) (2,293) $ (21,059)
Beginning balance (in shares) at Dec. 31, 2024   0 4,033        
Beginning treasury balance (in shares) at Dec. 31, 2024             (1,283)
Beginning balance at Dec. 31, 2024 40,428 $ 0 $ 4 494,209 (430,017) (2,717) $ (21,051)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (2,444)            
Ending balance (in shares) at Jun. 30, 2025   0 4,042        
Ending treasury balance (in shares) at Jun. 30, 2025             (1,287)
Ending balance at Jun. 30, 2025 40,130 $ 0 $ 4 494,838 (432,461) (1,169) $ (21,082)
Beginning balance (in shares) at Mar. 31, 2025   0 4,035        
Beginning treasury balance (in shares) at Mar. 31, 2025             (1,284)
Beginning balance at Mar. 31, 2025 39,474 $ 0 $ 4 494,595 (431,773) (2,293) $ (21,059)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation (in shares)     7        
Stock-based compensation 243     243      
Purchase of net settled restricted stock (in shares)             (3)
Purchase of net settled restricted stock (23)           $ (23)
Accumulated other comprehensive income (loss) 1,124         1,124  
Net loss (688)       (688)    
Ending balance (in shares) at Jun. 30, 2025   0 4,042        
Ending treasury balance (in shares) at Jun. 30, 2025             (1,287)
Ending balance at Jun. 30, 2025 $ 40,130 $ 0 $ 4 494,838 (432,461) (1,169) $ (21,082)
Beginning balance (in shares) at Dec. 31, 2025 3,755 2,691 5,366        
Beginning treasury balance (in shares) at Dec. 31, 2025 1,611           (1,611)
Beginning balance at Dec. 31, 2025 $ 65,707 $ 3 $ 5 530,136 (435,934) (1,364) $ (27,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation (in shares)     23        
Stock-based compensation 484     484      
Purchase of treasury stock (including payment of tax withholdings) (in shares)             (70)
Purchase of treasury stock (including payment of tax withholdings) (712)           $ (712)
Purchase of net settled restricted stock (in shares)             (1)
Purchase of net settled restricted stock (9)           $ (9)
Accumulated other comprehensive income (loss) (83)         (83)  
Dividends to holders of preferred stock (592)     (592)      
Net loss (3,793)       (3,793)    
Ending balance (in shares) at Mar. 31, 2026   2,691 5,389        
Ending treasury balance (in shares) at Mar. 31, 2026             (1,682)
Ending balance at Mar. 31, 2026 $ 61,002 $ 3 $ 5 530,028 (439,727) (1,447) $ (27,860)
Beginning balance (in shares) at Dec. 31, 2025 3,755 2,691 5,366        
Beginning treasury balance (in shares) at Dec. 31, 2025 1,611           (1,611)
Beginning balance at Dec. 31, 2025 $ 65,707 $ 3 $ 5 530,136 (435,934) (1,364) $ (27,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (5,641)            
Ending balance (in shares) at Jun. 30, 2026 3,699 2,776 5,398        
Ending treasury balance (in shares) at Jun. 30, 2026 1,699           (1,699)
Ending balance at Jun. 30, 2026 $ 59,797 $ 3 $ 5 530,922 (441,575) (1,528) $ (28,030)
Beginning balance (in shares) at Mar. 31, 2026   2,691 5,389        
Beginning treasury balance (in shares) at Mar. 31, 2026             (1,682)
Beginning balance at Mar. 31, 2026 61,002 $ 3 $ 5 530,028 (439,727) (1,447) $ (27,860)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation (in shares)   2 9        
Stock-based compensation 707     707      
Stock issued during period (in shares)   83          
Issuance of preferred stock 790     790      
Purchase of treasury stock (including payment of tax withholdings) (in shares)             (16)
Purchase of treasury stock (including payment of tax withholdings) (157)           $ (157)
Purchase of net settled restricted stock (in shares)             (1)
Purchase of net settled restricted stock (13)           $ (13)
Accumulated other comprehensive income (loss) (81)         (81)  
Dividends to holders of preferred stock (603)     (603)      
Net loss $ (1,848)       (1,848)    
Ending balance (in shares) at Jun. 30, 2026 3,699 2,776 5,398        
Ending treasury balance (in shares) at Jun. 30, 2026 1,699           (1,699)
Ending balance at Jun. 30, 2026 $ 59,797 $ 3 $ 5 $ 530,922 $ (441,575) $ (1,528) $ (28,030)